Aveanna Healthcare Price Target Cut to $1.00/Share From $2.00 by Credit Suisse
Aveanna Healthcare Cut to Underperform From Neutral by Credit Suisse
Aveanna Healthcare Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/27/2023 -23.66% Credit Suisse $2 → $1 Downgrades Neutral → Underperform 11/21/2022 129.01% RBC Capital
Credit Suisse Downgrades Aveanna Healthcare Hldgs to Underperform, Lowers Price Target to $1
Credit Suisse analyst A.J. Rice downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underperform and lowers the price target from $2 to $1.
Aveanna Downgraded to Underperform From Neutral at Credit Suisse
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSmileDirectClub (NASDAQ:SDC) stock increased by 47.0% to $0.71 during Monday's regular session. SmileDirectClub's stock is trading at a volume of 29.4 million shares as of 12:30 EST. This is 15
12 Health Care Stocks Moving In Friday's Intraday Session
GainersTC BioPharm (Holdings) (NASDAQ:TCBP) stock rose 90.6% to $8.5 during Friday's regular session. As of 12:30 EST, TC BioPharm (Holdings)'s stock is trading at a volume of 2.7 million, which is 35
FUV, ANGI and BARK Are Among Consumer Movers
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersYield10 Bioscience (NASDAQ:YTEN) shares increased by 59.5% to $3.35 during Wednesday's after-market session. This security traded at a volume of 341.5K shares come close, making up 1423.5% of i
Insiders Who Purchased Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Stock Last Year Recover Some Losses Which Currently Stand at US$313k
Loading...
No Stock Yet